Ding Y - Search Results

1

T₁ mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy.

Wang WT, Zhu S, Ding Y, Yang L, Chen CZ, Ye QH, Ji Y, Zeng MS, Rao SX. Wang WT, et al. Among authors: ding y. Eur J Radiol. 2018 Jun;103:25-31. doi: 10.1016/j.ejrad.2018.03.027. Epub 2018 Mar 28. Eur J Radiol. 2018. PMID: 29803381

2

Epithelioid angiomyolipoma of the liver: cross-sectional imaging findings of 10 immunohistochemically-verified cases.

Xu PJ, Shan Y, Yan FH, Ji Y, Ding Y, Zhou ML. Xu PJ, et al. Among authors: ding y. World J Gastroenterol. 2009 Sep 28;15(36):4576-81. doi: 10.3748/wjg.15.4576. World J Gastroenterol. 2009. PMID: 19777618 Free PMC article.

3

Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS. Ding Y, et al. Eur Radiol. 2014 Apr;24(4):959-66. doi: 10.1007/s00330-014-3096-y. Epub 2014 Jan 26. Eur Radiol. 2014. PMID: 24463697

4

Preoperative evaluation of colorectal liver metastases: comparison of gadopentetate dimeglumine and gadoxetic-acid-enhanced 1.5-T MRI.

Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS. Ding Y, et al. Clin Imaging. 2014 May-Jun;38(3):273-8. doi: 10.1016/j.clinimag.2013.12.021. Epub 2014 Jan 15. Clin Imaging. 2014. PMID: 24559747

5

Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.

Ding Y, Rao SX, Chen C, Li R, Zeng MS. Ding Y, et al. Eur Radiol. 2015 May;25(5):1392-8. doi: 10.1007/s00330-014-3542-x. Epub 2014 Dec 19. Eur Radiol. 2015. PMID: 25523455

6

Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.

Ding Y, Rao SX, Chen C, Li R, Zeng MS. Ding Y, et al. Hepatol Int. 2015 Apr;9(2):303-9. doi: 10.1007/s12072-014-9595-8. Epub 2014 Dec 6. Hepatol Int. 2015. PMID: 25788184

7

Usefulness of two-point Dixon fat-water separation technique in gadoxetic acid-enhanced liver magnetic resonance imaging.

Ding Y, Rao SX, Chen CZ, Li RC, Zeng MS. Ding Y, et al. World J Gastroenterol. 2015 Apr 28;21(16):5017-22. doi: 10.3748/wjg.v21.i16.5017. World J Gastroenterol. 2015. PMID: 25945017 Free PMC article.

8

Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.

Ding Y, Rao SX, Zhu T, Chen CZ, Li RC, Zeng MS. Ding Y, et al. Clin Radiol. 2015 Oct;70(10):1096-103. doi: 10.1016/j.crad.2015.04.014. Epub 2015 Jul 9. Clin Radiol. 2015. PMID: 26164421

9

Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine.

Chen CZ, Rao SX, Ding Y, Zhang SJ, Li F, Gao Q, Zeng MS. Chen CZ, et al. Among authors: ding y. Hepatol Int. 2014 Jan;8(1):104-11. doi: 10.1007/s12072-013-9467-7. Epub 2013 Aug 17. Hepatol Int. 2014. PMID: 26202411

10

[Potential values for diagnosis and assessment of nonalcoholic fatty liver disease staging using Gd+-EOB-DTPA-enhanced MRI].

Ding Y, Zeng M, Rao S, Chen C, Zhou X. Ding Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2015 Apr;23(4):297-9. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 26427081 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,715 results

Search Page

Filters